MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2022

Mar 6, 2022

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

7 March 2022

Mach7 Signs New Orders for Trinity Health and Penn State Milton S. Hershey Medical Center

Mach7 Technologies Limited (“ M7T” or “the Company” ) (ASX:M7T) today announced it has received signed agreements from two existing customers, Trinity Health and Penn State Milton S. Hershey Medical Center.

Trinity Health

Trinity Health has signed a statement of work (SOW). This (SOW) encompasses the first deployment wave of Trinity Health’s Unified Clinical Imaging Platform, which will see Mach7’s Enterprise Imaging Platform, Universal Worklist, eUnity Enterprise viewer and eUnity Diagnostic Viewer implemented at Trinity Health’s facilities across southeast Michigan. This SOW for Wave 1 has a total contract value of $0.9 million, which will be recognised as services revenue over the course of implementation from now through FY23.

Trinity Health will be deploying their solution in waves and each wave will have an independent order form for professional services. When fully implemented, the Mach7 solution will be implemented across 6 waves of multiple facilities within Trinity Health’s 92 hospitals, which are located across 22 states.

Penn State Milton S. Hershey Medical Center

Penn State Milton S. Hershey Medical Center (Penn State) has signed a contract renewal and license expansions for the Mach7 Enterprise Imaging Platform. The license renewal has a 2-year term and will cover 575,000 procedures annually. This contract includes 2 license expansions; one for increased volumes at Penn State’s current install site and one to expand the Mach7 solution to a new site in the network. The total contract value is $1.5 million of which $1.1 million is capital software revenue to be recognized in FY 22, and $0.4 million is support revenue to be recognised from now through March 2023.

“I am pleased to see continued adoption and growth from our current customers. This is a testament to the value of our products and the strength of our relationships.” stated Mike Lampron, CEO of Mach7. “The Mach7 solution will provide a strong core to Trinity Health’s Unified Clinical Imaging Platform Strategy, and Penn State has used Mach7 for years to handle large volumes of imaging procedures. I am proud that Mach7 continues to bring value to our customers as they seek to improve patient care.”

Released on authority of the Board by:

Mike Lampron Chief Executive Officer

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

For more information, contact:

CFO, Mach7: Investor Relations: Registered Office: Steve Parkes Simon Hinsley Level 4 | 100 Albert Road steve.parkes@mach7t.com NWR Communications South Melbourne, VIC +61 (0) 401 809 653 simon@nwrcommunications.com.au

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T), founded in 2007, is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organizations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Departmental Workflow applications. eUnity is a zerofootprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. With more than 150 customers across 15 different countries, Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com